Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Oxidative Stress-Induced miR-200c Is Upregulated in Psoriasis and Correlates with Disease Severity and Determinants of Cardiovascular Risk.

Oxidative medicine and cellular longevity·2020
Same author

Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation.

Bone marrow transplantation·2016
Same author

Development of protein bodies and accumulation of carbohydrates in a soybean (Leguminosae) shriveled seed mutant.

American journal of botany·2011
Same author

Levels of messenger-RNA coding for DNA topoisomerase-ii isoforms do not correlate with in-vitro drug-sensitivity.

Oncology reports·2011
Same author

Therapeutic activity of 9-chloro-2-methylellipticinium acetate in an orthotopic model of human brain cancer.

Oncology reports·2011
Same author

Capture probability of released males of two Bactrocera species (Diptera: Tephritidae) in detection traps in California.

Journal of economic entomology·2011

Related Experiment Video

Updated: Jul 12, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

A potential role for imaging technology in anticancer efficacy evaluations.

M G Hollingshead1, C A Bonomi, S D Borgel

  • 1Developmental Therapeutics Program, Division of Cancer Diagnosis and Treatment, National Cancer Institute, Bethesda, MD 20892, USA. hollingm@mail.nih.gov

European Journal of Cancer (Oxford, England : 1990)
|May 4, 2004
PubMed
Summary

New rodent imaging models using bioluminescence, like firefly luciferase, offer sensitive, non-invasive monitoring of anticancer drug efficacy. This technology enables real-time tumor tracking and molecular target evaluation in live animals.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Related Experiment Videos

Last Updated: Jul 12, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Area of Science:

  • Biomedical Imaging
  • Oncology Research
  • Preclinical Drug Development

Background:

  • Traditional rodent models for anticancer efficacy lack the sensitivity of advanced imaging techniques.
  • Bioluminescent imaging (BLI) offers precise, quantitative, and non-invasive detection of biological processes in live animals.
  • Firefly luciferase catalyzes a reaction emitting light, enabling visualization of biological events.

Purpose of the Study:

  • To highlight the potential of bioluminescent imaging in rodent models for advancing anticancer efficacy studies.
  • To explore the application of luciferase reporter systems for monitoring tumor growth and molecular targets.
  • To discuss the transformative impact of these imaging technologies on future drug testing.

Main Methods:

  • Utilizing sensitive charge-coupled device cameras for non-invasive detection of bioluminescent signals in vivo.
  • Employing tumor cells transfected with the luciferase gene for sequential monitoring of tumor growth.
  • Implementing luciferase reporter mechanisms in transgenic mice to study the tumor microenvironment and oncogenic events.

Main Results:

  • Bioluminescent endpoints provide higher sensitivity compared to traditional methods for assessing anticancer efficacy.
  • In vivo implantation of luciferase-transfected tumor cells allows non-invasive, sequential monitoring of tumor progression.
  • Inducible promoter systems and reporter mice facilitate the study of molecular-target modulation and tumor microenvironment dynamics.

Conclusions:

  • Bioluminescent imaging in rodents represents a significant advancement in preclinical anticancer efficacy models.
  • This technology enhances the ability to monitor tumor growth, evaluate drug responses, and study molecular targets non-invasively.
  • Bioluminescence-based approaches are poised to revolutionize future drug testing and efficacy evaluation algorithms.